41
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Activating (P253R, C278F) and Dominant Negative Mutations of FGFR2: Differential Effects on Calvarial Bone Cell Proliferation, Differentiation, and Mineralization

, , &
Pages 292-297 | Published online: 06 Aug 2009

References

  • Fantl, W.J., Johnson, D.E., and Williams, L.T. (1993). Signalling by re- ceptor tyrosine kinases. Ann. Rev. Biochem. 62:453–481.
  • Johnson, D.E., and Williams, L.T. (1993). Structural and functional diver- sity in the FGF receptor multigene family. Adv. Cancer Res. 60:1–41.
  • Rice, D.P., Aberg, T., Chan, Y., Tang, Z., Kettunen, P.J., Pakarinen, L., Maxson, R.E., and Thesleff, I. (2000). Integration of FGF and TWIST in calvarial bone and suture development. Development 127:1845–1855.
  • De Moerlooze, L., and Dickson, C. (1997). Skeletal disorders associated with fibroblast growth factor receptor mutations. Curr. Opin. Genet. Dev. 7:378–385.
  • Muenke, M., and Schell, U. (1995). Fibroblast-growth-factor receptor mu- tations in human skeletal disorders. Trends Genet. 11:308–313.
  • Celli, G., LaRochelle, W.J., Mackem, S., Sharp, R., and Merlino, G. (1998). Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J. 17:1642–1655.
  • Arman, E., Haffner-Krausz, R., Chen, Y., Heath, J.K., and Lonai, P. (1998). Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc. Natl. Acad. Sci. USA 95:5082–5087.
  • Arman, E., Haffner-Krausz, R., Gorivodsky, M., and Lonai, P. (1999). Fgfr2 is required for limb outgrowth and lung-branching morphogenesis. Proc. Natl. Acad. Sci. USA 96:11895–11899.
  • Hughes, S.H., Greenhouse, J.J., Petropoulos, C.J., and Sutrave, P. (1987). Adaptor plasmids simplify the insertion of foreign DNA into helper- independent retroviral vectors. J. Virol. 61:3004–3012.
  • Fekete, D.M., and Cepko, C.L. (1993). Replication-competent retrovi- ral vectors encoding alkaline phosphatase reveal spatial restriction of viral gene expression/transduction in the chick embryo. Mol. Cell Biol. 13:2604–2613.
  • Asahina, I., Sampath, T.K., Nishimura, I., and Hauschka, P.V. (1993). Human osteogenic protein-1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J. Cell Biol. 123:921–933.
  • Bikfalvi, A., Klein, S., Pintucci, G., and Rifkin, D.B. (1997). Biological roles of fibroblast growth factor-2. Endocr. Rev. 18:26–45.
  • Boudreaux, J.M., and Towler, D.A. (1996). Synergistic induction of os- teocalcin gene expression: Identification of a bipartite element conferring fibroblast growth factor 2 and cyclic AMP responsiveness in the rat osteo- calcin promoter. J. Biol. Chem. 271:7508–7515.
  • Anderson, J., Burns, H.D., Enriquez-Harris, P., Wilkie, A.M., and Heath, J.K. (1998). Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum. Mol. Genet. 7:1475–1483.
  • Siegel, P.M., and Muller, W.J. (1996). Mutations affecting conserved cys- teine residues within the extracellular domain of Neu promote recep- tor dimerization and activation. Proc. Natl. Acad. Sci. USA 93:8878–8883.
  • Neilson, K.M., and Friesel, R.E. (1995). Constitutive activation of fibrob- last growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J. Biol. Chem. 270:26037–26040.
  • Yu, K., Herr, A.B., Waksman, G., and Ornitz, D.M. (2000). Loss of fibrob- last growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc. Natl. Acad. Sci. USA 97:14536–14541.
  • Fragala, A., Tartaglia, M., Bernardini, S., Di Stasi, A.M.M., Di Rocco, C., Velardi, F., Teti, A., Battaglia, P.A., and Migliaccio, S. (1999). Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. Am. J. Pathol. 154:1465–1477.
  • Lomri, A., Lemonnier, J., Hott, A., de Parseval, N., Lajeunie, E., Munnich, A., Renier, D., and Marie, P.J. (1998). Increased calvarial cell differ- entiation and bone matrix formation induced by fibroblast growth fac- tor receptor 2 mutations in Apert syndrome. J. Clin. Invest. 101:1310–1317.
  • Mansukhani, A., Bellosta, P., Sahni, M., and Basilico, C. (2000). Sig- naling by fibroblast growth factors and fibroblast growth factor receptor 2 (FGFR2)-activating mutations block mineralization and induces apoptosis in osteoblasts. J. Cell Biol. 149:1297–1308.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.